CHOC Children's
Locations
Transplant Summary
Overview
Founded in 1986, the BMT Program at CHOC Children's offers a comprehensive range of pediatric BMT services for a wide variety of diagnoses and utilizes myeloablative and reduced intensity regimens. CHOC is a FACT-accredited, COG Phase 1, and has COE designation for several insurance carriers. Other Programs and Services: Special arrangements with Ronald McDonald housing or local hotels, AYA Program Type: Pediatric.This center has been performing allogeneic transplants since 1986 and has been an NMDP transplant center since December 1992.
Attending physicians
Adult - David Buchbinder, Rishikesh Chavan, Van Huynh, Ivan Kirov, Diane Nugent, Geetha Puthenveetil, Elyssa Rubin, Amit Soni, Lilibeth Torno
Pediatric - David Buchbinder, Rishikesh Chavan, Van Huynh, Ivan Kirov, Diane Nugent, Geetha Puthenveetil, Elyssa Rubin, Amit Soni, Lilibeth TornoTransplants performed
Marrow/PBSC, single cord, and double cordCord blood transplants
Pediatric onlyOther programs and services
Special arrangements with Ronald McDonald housing or local hotels, AYA, CAR-T cells.Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 39 patients.The actual 1-year survival of these patients is 81.8%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 78.5% and 97.9%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total pediatric transplants
57
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow28PBSC7Cord blood0Total35Unrelated donorMarrow3PBSC1Cord blood0Total4Total allogeneicMarrow31PBSC8Cord blood0Total39AutologousMarrowBoth marrow & PBSC 18PBSC—Cord blood—Total18Total combinedMarrowBoth marrow & PBSC 57PBSC—Cord blood0Total57All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-183219-44345-64065+0Total35Unrelated 0-18319-44145-64065+0Total4Autologous 0-181719-44145-64065+0Total18Total 0-185219-44545-64065+0Total57Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
After the Cancer Treatment Survivorship (ACTS) Program
1201 West La Veta Ave Orange, CA 92868 Phone:714-509-8636 For more information about this program: http://www.choc.org (Opens in a new tab)Overview
The After Cancer Treatment Survivorship program at the Hyundai Cancer Institute at CHOC Children's consists of a multidisciplinary team that provides comprehensive follow-up visits to evaluate your overall health concerns. Our specialists will also educate you and your family about the long-term effects of cancer treatment, fertility issues, education, employment rights and more.
Staff
Program Director:Lilibeth Torno, MDProgram Coordinator:Christine Yun, NPMedical Specialties in Program
Endocrinology, nutrition, social work, psychiatry/psychology.Medical Services Offered
Fertility counseling, reproductive health, nutrition/dietetics, pain management, sexual health, social services, vaccinations.Telemedicine services are available.Patient Eligibility
Children- Allogeneic and Autologous transplant recipients
- 1 after transplant.
- Patients who were transplanted as a child at this center up to age 25
- Does accept patients who were transplanted at another hospital
- Will admit pediatric patients who transferred into the program if they are under age 25
- Will accept adult patients who were transplanted as a child at another center up to age 25